Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma
Crossref DOI link: https://doi.org/10.1186/1749-8090-10-S1-A332
Published Online: 2015-12-16
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tsutani, Yasuhiro
Miyata, Yoshihiro
Mimura, Takeshi
Ito, Masaoki
Kai, Yuichiro
Kagimoto, Atsushi
Nakayama, Haruhiko
Okumura, Sakae
Yoshimura, Masahiro
Okada, Morihito
License valid from 2015-12-01
Article History
First Online: 16 December 2015